Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Calabresi

Showing results (71-80 of 169) with videos related to

Pageof 17
Sort By:
Archives of Internal Medicine|January 25, 2012
Severe high-density lipoprotein deficiency associated with autoantibodies against lecithin:cholesterol acyltransferase in non-Hodgkin lymphomaSara Simonelli, Elisabetta Gianazza, Giuliana Mombelli, et al.
Biochimica Et Biophysica Acta|September 2, 2005
High-density lipoproteins attenuate interleukin-6 production in endothelial cells exposed to pro-inflammatory stimuliMonica Gomaraschi, Nicoletta Basilico, Francesca Sisto, et al.
Biochemical Pharmacology|December 11, 2012
Off-target effects of thrombolytic drugs: apolipoprotein A-I proteolysis by alteplase and tenecteplaseMonica Gomaraschi, Alice Ossoli, Cecilia Vitali, et al.
Journal of Internal Medicine|November 11, 2021
The HDL mimetic CER-001 remodels plasma lipoproteins and reduces kidney lipid deposits in inherited lecithin:cholesterol acyltransferase deficiencyChiara Pavanello, Marta Turri, Arianna Strazzella, et al.
Blood Advances|April 23, 2021
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNsManjola Balliu, Laura Calabresi, Niccolò Bartalucci, et al.
Atherosclerosis Plus|July 24, 2025
Lipidome of high-density lipoprotein is strongly perturbed in hyperalphalipoproteinemia resulting from a rare mutation in endothelial lipaseLivia Pisciotta, Marie Lhomme, Chiara Pavanello, et al.
Journal of Clinical Lipidology|August 3, 2019
Individuals with familial hypercholesterolemia and cardiovascular events have higher circulating Lp(a) levelsChiara Pavanello, Carlo Pirazzi, Kristina Bjorkman, et al.
Pharmacological Research|July 23, 2019
Treatment with fibrates is associated with higher LAL activity in dyslipidemic patientsChiara Pavanello, Andrea Baragetti, Adriana Branchi, et al.
Antioxidants (Basel, Switzerland)|August 26, 2023
Abnormal Lipoproteins Trigger Oxidative Stress-Mediated Apoptosis of Renal Cells in LCAT DeficiencyMonica Gomaraschi, Marta Turri, Arianna Strazzella, et al.
Current Vascular Pharmacology|February 21, 2012
Lipid and apoprotein composition of HDL in partial or complete CETP deficiencyEric J Niesor, Elisabeth von der Mark, Laura Calabresi, et al.
Pageof 17

Showing results (71-80 of 169) with videos related to

Sort By:
Pageof 17
Archives of Internal Medicine|January 25, 2012
Severe high-density lipoprotein deficiency associated with autoantibodies against lecithin:cholesterol acyltransferase in non-Hodgkin lymphomaSara Simonelli, Elisabetta Gianazza, Giuliana Mombelli, et al.
Biochimica Et Biophysica Acta|September 2, 2005
High-density lipoproteins attenuate interleukin-6 production in endothelial cells exposed to pro-inflammatory stimuliMonica Gomaraschi, Nicoletta Basilico, Francesca Sisto, et al.
Biochemical Pharmacology|December 11, 2012
Off-target effects of thrombolytic drugs: apolipoprotein A-I proteolysis by alteplase and tenecteplaseMonica Gomaraschi, Alice Ossoli, Cecilia Vitali, et al.
Journal of Internal Medicine|November 11, 2021
The HDL mimetic CER-001 remodels plasma lipoproteins and reduces kidney lipid deposits in inherited lecithin:cholesterol acyltransferase deficiencyChiara Pavanello, Marta Turri, Arianna Strazzella, et al.
Blood Advances|April 23, 2021
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNsManjola Balliu, Laura Calabresi, Niccolò Bartalucci, et al.
Atherosclerosis Plus|July 24, 2025
Lipidome of high-density lipoprotein is strongly perturbed in hyperalphalipoproteinemia resulting from a rare mutation in endothelial lipaseLivia Pisciotta, Marie Lhomme, Chiara Pavanello, et al.
Journal of Clinical Lipidology|August 3, 2019
Individuals with familial hypercholesterolemia and cardiovascular events have higher circulating Lp(a) levelsChiara Pavanello, Carlo Pirazzi, Kristina Bjorkman, et al.
Pharmacological Research|July 23, 2019
Treatment with fibrates is associated with higher LAL activity in dyslipidemic patientsChiara Pavanello, Andrea Baragetti, Adriana Branchi, et al.
Antioxidants (Basel, Switzerland)|August 26, 2023
Abnormal Lipoproteins Trigger Oxidative Stress-Mediated Apoptosis of Renal Cells in LCAT DeficiencyMonica Gomaraschi, Marta Turri, Arianna Strazzella, et al.
Current Vascular Pharmacology|February 21, 2012
Lipid and apoprotein composition of HDL in partial or complete CETP deficiencyEric J Niesor, Elisabeth von der Mark, Laura Calabresi, et al.
Pageof 17